Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • March4NETs
NET Nurse
Donate

Home » News » ENETS-INCA NET Cancer Day Educational Webinar

ENETS-INCA NET Cancer Day Educational Webinar

  • October 21, 2021

We are delighted to invite you to the ENETS-INCA NET Cancer Day Educational Webinar on Wednesday, 10 November 2021.

This  webinar addresses explicitly the patients’ view.

It will be interactive with interesting examples, live polling, panel discussions, and audience participation via a Q+A tool!

JOINING INSTRUCTIONS

Date: Wednesday, 10 November 2021

Time: 12:00 – 14:15 Central European Time (CET)

Where: https://www.enets.org/net-cancer-awareness-day.html

This ENETS webinar is free of charge and no registration is necessary.

 

Agenda

 

12:00 – 12:10 | OPENING

Catherine BOUVIER (INCA President, GBR) and Marianne PAVEL (ENETS Chair, GER)

 

12:10 – 12:40 | PART ONE | The Facts: Incidence and Prevalence of NENs globally

Gregory KALTSAS (Endocrinologist, GRE) and Staffan WELIN (Endocrine Oncologist, SWE)

12:10 – 12:20  Talk

12:20 – 12:40  Q+A session

 

12:40 – 13:10 | PART TWO | Patient reported treatment side effects: What causes the side effects in NEN treatments and strategies for side effect management

Angela LAMARCA (Oncologist, GBR) and Simona GLASBERG (Endocrinologist, ISR)

12:40 – 12:50  Talk

12:50 – 13:10  Q+A session

 

13:10 – 13:40 | PART THREE | Patients as partners in NEN Research: Key focal points of research from genomics to organoids. What is it all telling us, and are patient views being truly considered?

●Where are we now, what do we know, and what do we need to further investigate?
●Role of patients in research

Enrique GRANDE (Oncologist, ESP) and Anja RINKE (Gastroenterologist, GER)

13:10 – 13:20  Talk

13:20 – 13:40  Q+A session

 

13:40 – 14:10 | PART FOUR | Nutrition in NENs

●Patient case history given by the patient around issues with diet and nutrition. A dietician, doctor and nurse offering solutions to these issues:

Wanda GEILVOET (Nurse, NED), Dietitian (tbd), and Elisabeth NIEVEEN VAN DIJKUM (Surgeon, NED)

13:40 – 13:50  Talk

13:50 – 14:10  Q+A session

 

14:10 – 14:15 | CLOSING

Catherine BOUVIER (INCA President, GBR) and Marianne PAVEL (ENETS Chair, GER)

 

Click here to join

Share this post

Recent posts

VHL Awareness Month 2025

May 6, 2025

NET Patient Chris, from Ballarat, Raises Awareness of Neuroendocrine Cancer

May 5, 2025

Help Us Grow: Connect NECA with Corporate Partners to Make a Lasting Impact

April 29, 2025

Neuroendocrine Cancer Awareness Daily Mail 5 April 2025

April 5, 2025
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousProvectus Biopharmaceuticals Announces Presentation of Full Study Data from Metastatic Neuroendocrine Cancer Phase 1 Trial of PV-10® at European Society for Medical Oncology (ESMO) Congress 2021
NextNET Connect Meeting SeriesNext

Related Posts

VHL Awareness Month 2025

May is internationally recognised as Von Hippel-Lindau (VHL) Awareness Month—a time to highlight this rare genetic, and in some case not genetic, condition and the

NET Patient Chris, from Ballarat, Raises Awareness of Neuroendocrine Cancer

NeuroEndocrine Cancer Australia (NECA) is proud to recognise the advocacy efforts of NET patient Chris Geljon, who has taken the time to raise awareness of

Neuroendocrine Cancer Awareness Daily Mail 5 April 2025

Jo O’Halloran was in her early fifties when the symptoms she and her friends had heard so much about started to appear. ‘I was always

Neuroendocrine Cancer in Budget 2025–26

The 2025–26 Federal Budget, delivered by the Treasurer Hon Jim Chalmers on 25th March, included a welcome investment of $256.2 million over four years from 2025–26 (and

View All

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2025 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin